Increasing the concentration of oxygen dissolved in water is known to increase the recovery rate (R1 ¼ 1/T1) of longitudinal magnetization (T1 relaxation). Direct T1 changes in response to precise hyperoxic gas challenges have not yet been quantified and the actual effect of increasing arterial oxygen concentration on the T1 of brain parenchyma remains unclear. The aim of this work was to use quantitative T1 mapping to measure tissue T1 changes in response to precisely targeted hyperoxic respiratory challenges ranging from baseline end-tidal oxygen (PetO 2 ) to approximately 500 mmHg. We did not observe measureable T1 changes in either gray matter or white matter parenchymal tissue. The T1 of peripheral cerebrospinal fluid located within the sulci, however, was reduced as a function of PetO 2 . No significant T1 changes were observed in the ventricular cerebrospinal fluid under hyperoxia. Our results indicate that care should be taken to distinguish actual T1 changes from those which may be related to partial volume effects with cerebrospinal fluid, or regions with increased fluid content such as edema when examining hyperoxia-induced changes in T1 using methods based on T1-weighted imaging.
Introduction
Interest in the effect of inhaled oxygen (O 2 ) on MR image contrast in T1-weighted images began with the observation of cerebrospinal fluid (CSF) hyper-intensity in fluid-attenuated inversion recovery (FLAIR) images taken of patients under general anesthesia. Initially thought to be the result of hemorrhage or abnormal protein content, CSF hyper-intensity was later shown to be due to the administration of supplemental O 2 . 1,2 CSF mainly consists of unbound water molecules, and increasing the concentration of O 2 dissolved in water causes a decrease longitudinal magnetization: defined by the T1 relaxation time constant. 3 In the context of FLAIR images, T1 shortening results in a shift of the inversion time required to null the CSF, thereby resulting in unexpected MR signal. Subsequent in vivo studies examining the effect of increased O 2 inhalation (defined herein as hyperoxia) have reported further O 2 -dependent T1 changes in various peripheral organs and tissues, 4-6 blood, 7-9 cerebral tissue 10 and in CSF. 11, 12 The notion that dissolved O 2 can modulate MR relaxivity in vivo has spurred the development of MR methods with the aim of quantifying changing tissue oxygenation properties under varying gas inhalation challenges. Recent studies have used steady-state MR imaging 13 as well as saturation-recovery-based methods 10 to investigate changes in the T1-recovery-induced via high-flow hyperoxic gas mixtures, as potential surrogate markers of tissue oxygenation status. It has been suggested that monitoring changes in relaxivity parameters can help identify brain regions in which metabolic homeostasis is perturbed, or where O 2 supply has been compromised. 13, 14 This is of particular interest for oncological studies since tissue hypoxia has been associated with negative treatment outcome. 15, 16 While studies in the parametric assessment of tissue oxygenation have shown initial promise, potential confounds relating to image acquisition and respiratory challenge delivery, mean that uncertainties remain regarding the actual extent by which parenchymal tissue (consisting of a majority extravascular tissue fraction and minority blood fraction) T1 is changed under hyperoxia. The use of T1-weighted imaging provides only an indirect measure of T1 changes which may be influenced by global susceptibility effects related to large volumes of inspired O 2 17 or partial volume effects with CSF, and perhaps to a lesser extent, residual blood oxygenation level-dependent (BOLD) T 2 * weighting or inflow effects. In terms of gas delivery, the use of high-flow gas mixtures such as carbogen or pure O 2 provides a stimulus whose amplitude and temporal characteristics may vary between subjects. This makes investigation of T1 changes as function of inspired gas concentration challenging.
To date, direct T1 changes in response to precise hyperoxic gas challenges have not been quantified in healthy human parenchyma. This is likely due to the extended scan duration required, combined with the need to perform repeated measurements under various hyperoxic states. Thus, the actual effect of increasing arterial O 2 concentration on cerebral tissue T1 remains uncertain. The aim of this work was to use fast, highresolution direct T1 mapping at 7T to measure brain tissue and CSF T1 changes in response to precisely controlled hyperoxic respiratory challenges.
Materials and methods

Breathing protocol
This study was approved by the Medical Research Ethics Committee (MREC) of our institution and written informed consent was obtained from all subjects. The experiments were performed according to the guidelines and regulations of the WMO (Wet Medisch Wetenschappelijk Onderzoek). Ten Healthy subjects (3 female, 30 AE 7 years) were scanned on a Philips 7T magnetic resonance imaging (MRI) scanner using a dual-transit head coil in combination with a 32 channel receive coil (Nova Medical, Wilmington Ma, USA). Precise targeting of end-tidal O 2 partial pressure (PetO 2 ) was accomplished using a RespirAct TM system (Thornhill Research, Toronto, CAN). The RespirAct device consists of a computer controlled gas blender which connected to four input gases: medical air, 100% oxygen, 10%/20%/70% CO 2 /O 2 /N 2 mixture and 10%/90% O 2 /N 2 mixture. An output line connects the blender to a rebreathing circuit which is taped to the subject to ensure an airtight seal using Tegaderm film (3 M, Maplewood, MN, USA). Two sensor lines are connected which monitor end-tidal gas values and breathing pressure. The rebreathing circuit described in ensures that all gas delivered to the subject is inhaled, facilitating precise targeting of end-tidal gas values. An in-depth description of the breathing circuit and the theory behind the sequential gas delivery system can be found in Slessarev et al. 18 Separate whole brain T1 maps were acquired during four targeted PetO 2 levels. PetO 2 targets were randomized and included baseline (approximately 110 mmHg), 250 mmHg, 350 mmHg, and 500 mmHg (see Figure 1 ). To examine potential time-dependent T1 changes in response to a large hyperoxic stimulus, two additional T1 maps were acquired during hyperoxic stimulus targeted with PetO 2 targeted at 500 mmHg. Including the initial time allowed for the PetO 2 values to stabilized, acquisition of the three consecutive T1 maps was completed after approximately 6, 10, and 14 minutes. Throughout the course of the imaging protocol, end-tidal CO 2 (PetCO 2 ) was maintained at individual subject baseline levels in order to minimize vasodilation-related flow effects.
Image acquisition & T1 fitting
Prior to T1 mapping, a B 0 map was acquired (3D gradient-echo, TR/TE: 4/1.54 ms, scan duration: 11.4 s, reconstructed resolution: 3.75 mm 3 , slices: 29, FOV: 240 Â 112.5 Â 180 mm 3 , flip angle: 10 ). This map was used to perform third-order image-based B 0 shimming. T1 maps were acquired using a non-slice selective adiabatic inversion pulse, which served to minimize inflow effects relating to limited transmit coil volume, followed by sequential acquisition of slices at increasing inversion times along the T1 recovery curve. This process was repeated over 23 scans. For each repetition, the acquired slice order was shifted such that each slices were acquired at 23 distinct inversion times -for details see Polders et al. 19 Scan parameters were as follows: multi-slice single-shot echo planar imaging (EPI), inversion time range: 132.2-5074.4 ms, inversion time spacing: 224.6 ms, TR/TE: 10,000/9.42 ms, scan duration: 4 min, reconstructed resolution: 1 Â 1 Â 1.5 mm 3 , slices: 46, FOV: 224 Â 224 Â 91.5 mm 3 , flip angle: 150 , SENSE factor: 3.6 (AP), Halfscan factor: 0.61. Post processing was done using an IDL tool whereby slices were re-ordered and temporally consistent image volumes were reconstructed. From here, a voxel-wise T1 fit was performed assuming complete inversion (i.e. a two parameter fit) to generate whole brain, high-resolution T1 maps. Further details pertaining to this T1 mapping method are described in literature. [19] [20] [21] 
Data processing
Brain tissue was extracted from each T1 map by manual delineation (10 subjects Â 4 O 2 levels ¼ 40 T1 maps in total). A whole brain probability density histogram was generated from each brain extracted T1 map. Normalized histograms representing T1 values at each O 2 level were then averaged together such that global T1 changes in response to hyperoxia could be investigated. The approximate histogram bin-width was 7 ms. To examine regional changes, binary ROI masks were created by thresholding of individual T1 maps using the following T1 values derived from the mean whole brain histogram: white matter (WM): 800-1300 ms, gray matter (GM): 1300-1900 ms, and total cerebrospinal fluid (CSF Total ): 3000 msþ). The CSF Total masks (see Figure 2 (a)) were manually segmented to isolate CSF located in the ventricles (CSF v ) and sulci (CSF s ). ROI masks were eroded using a 2D diamond-shaped kernel with a center-to-edge width of one voxel to reduce partial volume effects at tissue interfaces. T1 changes were investigated in regions showing an observable T1 response to hyperoxia and resulted in an estimate of relaxivity (r1) for O 2 dissolved in CSF via linear regression of R1 (R1 ¼ 1/T1) as a function of PetO 2 . An additional R1 value was fitted based on the single subject T1 data in which three T1 maps were acquired at a targeted PetO 2 of 500 mmHg. This fit was performed using the T1 data acquired during the baseline period and the average T1 data from the T1 maps acquired during the two final hyperoxic periods (approximately 6-15 min after onset of hyperoxic stimulus).
Statistical analysis
The average and standard deviation of median T1 values were calculated for all subjects in each GM, WM, and CSF ROI. Median values were chosen to alleviate the effect of outlying T1 values and also due to the fact that regional T1 values were not normally distributed. Other measured data is reported as mean AE standard deviation. T1 changes in response to hyperoxic challenges from each ROI were tested for significance using a one-way ANOVA with three degrees of freedom.
Results
Subjects reported no discomfort relating to the hyperoxic breathing challenges. Aside from the mean intersubject baseline PetO 2 (mean AE standard deviation: 109 AE 2 mmHg), achieved PetO 2 values averaged across all 10 subjects were 247 AE 2 mmHg, 349 AE 1 mmHg, and 487 AE 1 mmHg for the three respective hyperoxic challenges. Each subjects PetCO 2 were maintained at their individual baseline value. The average PetCO 2 across all subjects was 36 AE 2.5 mmHg and the average intra-individual standard deviation (of baseline PetCO 2 over the duration of a hyperoxic challenge) was 1.4 AE 0.5 mmHg.
In general, the data quality associated with the T1 fitting procedure was high ( Figure 2 ). This facilitated robust fitting of voxel-wise T1 values; average probability density histograms for whole brain at each O 2 level are shown in Figure 4 . Corresponding box plots generated based on ROIs indicated in Figure 3 (a) are shown in Figure 5 . No significant differences were observed in (Table 1) . T1 values in CSF Total were significantly different (p < 1 Â 10 À6 , F(3) ¼ 15.9) and became shorter with increasing PetO 2 . This shortening was mainly due to T1 changes in CSF S (p < 1 Â 10 À10 , F(3) ¼ 24.19), as limited changes were seen in CSF V (p ¼ 0.7, F(3) ¼ 0.28). The fitted r1 of O 2 in CSF S and CSF V were 3.3e À5 s À1 /mmHg (adj. R 2 ¼ 0.97, RMSE ¼ 1.2e À3 ) and 3.8e À6 s À1 /mmHg (adj. R 2 ¼ 0.35, RMSE ¼ 6.1e À4 ), respectively (Table 1, Figure 5 ). The average number of voxels included in the CSF S and CSF V masks across all subjects and O 2 levels were 12854 and 2476, respectively. Whole brain probability density histograms of T1 values calculated at each O 2 level are shown for a single subject in Figure 3 (b). Comparison of intrasubject T1 histograms highlights the robustness of the T1 mapping procedure. T1 values associated with GM and WM tissue appear unchanged, while those of CSF were notably shortened. In this particular subject, an additional two T1 maps were acquired during the 500 mmHg PetO 2 target in order to investigate potential delays in O 2 -induced T1 effects. While a further decrease in CSF T1 was observed in the second T1 map, limited changes were observed in the third T1 map (Figure 3 O 2 of 1.306 Â 10 À5 s À1 /mmHg (see Figure 6 ). The fit offset was 0.2507 s À1 , which corresponds to an O 2 -free CSF S T1 of approximately 3851 ms in this particular subject.
Discussion
Main findings
We did not observe significant changes in either GM, WM T1 values as a function of PetO 2 . There was an inverse relationship between PetO 2 and T1 in the CSF S , however. Reductions in T1 of the ventricles were not significant, confirming previous results from the literature. 3, 11, 12 However, baseline T1 in the CSF V was higher than in the CSF S . CSF Total T1 values were in line with those reported by Hopkins et al., 22 who found an average T1 in CSF (including CSF V and CSF S ) of approximately 4.3 s for measurements made between 0.15 and 1.4 T. Furthermore, our CSF Total T1 results follow those reported by Rooney et al. 23 who measured a CSF Total T1 at 7T of 4425 AE 137, thus lending further support to the observation that CSF T1 is relatively field strength independent. This does not seem to be the case for the r1 of dissolved oxygen, however. Our fitted r1 of O 2 in CSF S (3.3e À5 s À1 /mmHg) was an order of magnitude smaller than that found by Zaharchuk et al. 24 for the r1 of dissolved O 2 in distilled water (2.49 e À4 s À1 /mmHg) 24 and artificial CSF (2.7 e À4 s À1 /mmHg) 11 measured at 1.5 T. This discrepancy is likely due to the fact that we used a surrogate measure of oxygenation changes in PetO 2 , and that our measurements were performed in vivo at a higher field strength. Finally, the time required to reach peak CSF Total T1 changes in response to the most prolonged hyperoxic step used in our experiments was on the order of 10-12 min. These time-to-peak values are in agreement with those reported in literature [25] [26] [27] of approximately 10-15 minutes. Potential factors, in addition to baseline pO 2 , which could lead to variations in CSF T1 include differences in temperature or CSF protein content. It is unlikely, however, that significant temperature variations exist between peripheral and central regions of the head. Furthermore, the T1 relaxivity of proteins contained within the CSF, along with their concentrations, is low. Variations in CSF protein content large enough to cause significant signal effects are only likely in disease situations. 25 Thus, we do not expect variations in temperature or protein content to explain the regional T1 differences measured in our healthy subject group. Variation between CSF S and CSF V may be partially attributed to differences in O 2 content. The CSF compartment provides a considerable reservoir of unbound water, into which plasma O 2 is able to diffuse from the vasculature. Due to the large network of vessels located on the cortical surface, effectively increasing the surface area through which O 2 can diffuse, it stands to reason that the amount of O 2 diffusing into the CSF S is higher than that to the CSF V . Conclusions drawn from previous animal studies have indicated direct diffusion of O 2 between arteries and CSF, 26, 28 and this mechanism has also been discussed in the context of T1 changes in human studies by Mehemed et al. 12 The large volume occupied by the ventricles may also explain the elevated baseline T1 in CSF V . It is likely CSF S mask erosion did not completely eliminate partial volume effects between CSF S and the surrounding vasculature and tissues that have much lower T1 values; especially since our volunteer group consisted of young subjects. Thus, CSF S voxels may have contained a larger tissue/vasculature fraction than those selected in the CSF V . Small changes in blood volume fraction due to hyperoxia-mediated Figure 6 . The solid red line depicts the CSF S relaxivity (r1-s À1 /mmHg PetO 2 ) fitted based on the median T1 values averaged across 10 subjects in CSF S (adj R 2 ¼ 0.94). For reference, individual subject data points and associated fit results for individual subjects are shown in grey. Additional T1 maps were acquired at high PetO 2 in a single subject to investigate whether there was a time dependency on T1 changes. An additional relaxivity calculated based on single subject (Figure 3(b) ) T1 values at baseline and after approximately 10 min of hyperoxia with PetO 2 targeted at 500 mmHg is depicted by the solid blue line. The fit result based on this single subject across the increasing PetO 2 values is highlighted by the dashed blue line (rather than solid grey as with the remaining 9 subjects). Changes in CSF V were not significant, and are not shown.
vasoconstriction could lead to a local reduction in CBV which may raise intra-voxel T1 via a higher fractional CSF T1 contribution. However, this effect was not observed in our data. Subsequent studies using varying voxels size can aid elucidating what the exact contribution is of partial volume effects of CSF S with the pial vasculature and adjacent tissues. The lack of T1 changes in CSF V may be explained by the ratio of CSF to vessel density in that region compared to CSF S . The ventricles compose a large reservoir of CSF where the slow dilution of O 2 could mitigate O 2 -dependent T1 reduction.
An interesting result in our study was the absence of detectable T1 changes in the brain parenchyma despite studies reporting tissue pO 2 increases under hyperoxia directly using oxygen probes in the healthy brain tissue of comatose patients 29 or those suffering from severe traumatic brain injury. 30, 31 In these cases, changes in cerebral hemodynamics may have played a role in the tissue response to hyperoxia. Our results support findings in healthy subjects which are reported in Anzai et al., 3 where comparison of FLAIR image signal intensity changes under hyperoxia did not identify O 2related effects in the brain parenchyma or in the lateral ventricles. Our findings are also in line with the work of Zaharchuk et al., 11 who also failed to identify O 2 -dependent tissue T1 changes, reporting only changes in the sulci and basilar cisterns. It should be noted, however, that the sequences used in these studies were optimized for sensitivity to changes at the higher T1 values of CSF than those typically found in tissues.
For the levels of O 2 used in our study, arterial oxygen saturation in our healthy volunteers was presumably between 98 and100%. 32 Notwithstanding potential vasoactive effects, it is known that hyperoxia results in a BOLD signal due to increased venous hemoglobin saturation. 33 This suggests that, under hyperoxia, the extravascular tissue O 2 demand is partially satisfied by a larger proportion of plasmadissolved O 2 rather than O 2 that would normally have been released from hemoglobin. If we also consider the amount of O 2 that diffuses into the CSF, 26 it could be that the blood-tissue O 2 gradient is simply not as large as might be expected. For this reason, no significant increases in O 2 diffusion across the blood-brain barrier would occur and extravascular tissue T1 would remain largely unchanged. Or, the increased O 2 which enters the tissues is immediately metabolized and does not contribute to T1 shortening. This would mean CMRO 2 would slightly increase under hyperoxia. Direct measurements of tissue CMRO 2 under hyperoxia, for instance using PET or O 17 imaging, seem warranted to unequivocally rule out this effect.
This interpretation of our results challenges the results presented in literature; 10, 13 however, these studies did not employ quantitative imaging methods or precise gas control. It is conceivable that in-flow effects as well as residual BOLD T2* weighting at short TE, partial volume effects with CSF or global susceptibility effects relating to increasing oxygen gas concentration 17 may have resulted in apparent tissue-O 2 -related signal changes. Note, however, that inflow effects by vasoconstriction or a drop in end-tidal pCO 2 under hyperoxia and global susceptibility effects would result in an apparent T1 increase in T1-weighted sequences instead of the reported T1 decreases. This leaves residual BOLD T2* effects and partial volume effects with CSF as the most likely candidates for confounding apparent T1 reductions seen in tissue. Inversion recovery T1 mapping is insensitive to such confounds, since they are constant throughout the acquisition and are negated when fitting the T1 decay curve. On a voxel level, the error associated with T1 mapping method we have used is on the order of 1-1.5%. 19 This translates to T1 variance of approximately 15-25 ms in GM. If tissue T1 does in fact shorten in response to hyperoxia, then changes must be under the threshold ($15 ms) of our ability to detect them using our T1 mapping method. A similar conclusion can be made with regard to changes in blood water T1. Shortening of blood T1 due to dissolved O 2 in the plasma is expected, however, since the blood fraction in a voxel is small ($2-5% 34 ), blood T1 changes are presumably diluted by extravascular tissue T1 contributions.
Direct measurement of pO 2 in human CSF has been limited due to the invasive nature of the oxygenation measurements. [35] [36] [37] Nevertheless, there is evidence that reduced CSF oxygen partial pressure in patients can be used as a possible biomarker to identify cerebral disease and brain injury. While we did not measure tissue T1 changes in response to hyperoxia, the changes observed in the CSF may serve as a benchmark from which to identify anomalies in CSF T1 stemming from cerebral metabolic dysfunction.
Considerations
Both animal 26 and human 11 studies have quoted timeto-peak delays of approximately 10-12 min for T1 changes in the CSF. This was also apparent in our study and is illustrated in Figure 3 (b), where CSF T1 values continue to decrease during subsequent T1 map acquisitions at high PetO 2 . This indicates that T1 values were changing throughout our acquisition; this likely lead to an increased variance within our data. Furthermore, the relatively short scan-time ($4 min) of our T1 mapping sequence has likely resulted in an underestimation of actual O 2 -dependent T1 changes. The extent of this effect can be inferred based on the additional single subject relaxivity estimations provided in Figure 6 . Ideally, future experiments should allow for up to 15 min for pO 2 levels in the CSF to equilibrate.
Notwithstanding the normal inter-subject variation in baseline values, the variance in PetCO 2 remained minimal throughout the hyperoxic challenges. Thus, potential arterial oxygenation changes due to vasodilatory increases in CBF were minimal. This may not be true in experiments relying on free-breathing gas delivery methods that do not clamp arterial CO 2 . The potential vasoconstrictive effect of hyperoxia remains a topic of debate and it is uncertain how small reductions in CBF would affect our results given that oxygen saturation and the concentration of plasma-dissolved O 2 will nevertheless remain high.
Conclusion
Despite the fact that we did not detect tissue T1 changes, we provided a reference point for T1 values is CSF as a function of PetO 2 . Future human studies examining potential tissue T1 changes under targeted hyperoxia in tissues with metabolic disorder are required. Moreover, care should be taken to distinguish actual parenchymal tissue T1 changes from those which may be related to partial volume effects with CSF or regions with increased fluid content such as edema.
